A Trial Evaluating the Clinical Efficacy and Safety of Hibero SR (Mirabegron) 50 mg and Ditropan (Oxybutynin Chloride) 10 mg in Children Between 5 and 18 Years With Overactive Bladder (OAB)
Clinical trial NCT06181591 · UNKNOWN
Trial details
- NCT number
- NCT06181591
- Sponsor
- Seoul National University Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-01
- Primary completion
- 2025-04-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.